Welcome
Support Centre
23 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Overcoming your child's fears and worries: a self-help guide for childhood anxiety disorders
ISRCTN ISRCTN92977593
ClinicalTrials.gov identifier
Public title Overcoming your child's fears and worries: a self-help guide for childhood anxiety disorders
Scientific title Overcoming your child's fears and worries: a randomised controlled trial of guided self-help for childhood anxiety disorders
Acronym Overcoming
Serial number at source v06.02.2008
Study hypothesis In a randomised controlled trial of childhood anxiety (in the absence of a current maternal anxiety disorder) the principal research questions are:
1. Does full guided self-help CBT lead to a reduction in anxiety disorder diagnoses, in comparison to a wait-list control?
2. Does less intense guided self-help CBT lead to a reduction in anxiety disorder diagnoses, in comparison to a wait-list control?

Secondary research questions:
3. Does full guided self-help Cognitive behaviour therapy (CBT) lead to a reduction in anxiety symptoms, in comparison to a wait-list control?
4. Does less intense guided self-help CBT lead to a reduction in anxiety symptoms, in comparison to a wait-list control?
5. Are specific parenting practices (over involvement, fear expression) and thinking styles (expectations about child competency) associated with child treatment outcome (symptoms/ diagnosis)?
Lay summary Lay summary under review
Ethics approval Berkshire Research Ethics Committee approved on 16 November 2007, ref: 07/H0505/157
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Child anxiety disorder
Participants - inclusion criteria 1. Aged 7 to 12 years
2. Primary diagnosis of Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) generalised anxiety disorder, social phobia, separation anxiety disorder, panic disorder/agoraphobia or specific phobia
3. Parent / primary carer attends treatment
Participants - exclusion criteria Child:
1. Significant physical or intellectual impairment (including autistic spectrum disorders)
2. Current prescription of psychotropic medication (or, if psychotropic medication is prescribed, it should have been at a stable dose for at least one month with agreement to maintain that dose throughout the study)

Parent(s):
1. Current maternal DSM-IV anxiety disorder
2. Significant intellectual impairment
3. Severe comorbid disorder (e.g. severe major depressive disorder, psychosis, substance /alcohol dependence)
4. Prescription of psychotropic medication (or, if psychotropic medication is prescribed, it should have been at a stable dose for at least one month with agreement to maintain that dose throughout the study)
Anticipated start date 25/04/2008
Anticipated end date 30/12/2011
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 195
Interventions Guided Cognitive Behaviour Therapy (CBT) self-help delivered via parents:
1. 8 sessions (4 face to face, 4 telephone)
2. 4 sessions (2 face to face, 2 telephone)
Primary outcome measure(s) 1. Clinical Global Impressions of Improvement (CGI-I) (Much / Very much improved or not)
2. Anxiety Disorders Interview Schedule for DSM IV (child and parent versions) (ADIS-C/P) (Child free of primary anxiety disorder or not)
Secondary outcome measure(s) 1. Child anxiety symptoms and impact (SCAS, Spence, 1998- child/parent/teacher report; CAIS, Langley et al., 2004 - child/parent report)
2. Parental interactive behaviours and cognitions as assessed by interview and observations
Sources of funding Medical Research Council (MRC) (UK) (ref: G0802326)
Trial website
Publications
Contact name Prof  Peter  Cooper
  Address School of Psychology and Clinical Language Sciences
University of Reading
Reading
  City/town Berkshire
  Zip/Postcode RG6 6AL
  Country United Kingdom
Sponsor University of Reading (UK)
  Address c/o Dr M J Proven
Research and Enterprise Services
Reading
  City/town Berkshire
  Zip/Postcode RG6 6AL
  Country United Kingdom
  Sponsor website: http://www.reading.ac.uk
Date applied 06/10/2011
Last edited 22/11/2011
Date ISRCTN assigned 22/11/2011
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central